Vaccine Insights
Collecting data on vaccines, policies, and public concerns extensively.
The rapid development of mRNA vaccines during the COVID-19 pandemic (only 11 months from strain detection to the first dose) has tested the breakthrough response capabilities of vaccine technology, with more than 13 billion doses distributed worldwide, reducing more than 20 million deaths.
The relationship between vaccines and herd immunity: When the vaccination rate reaches a threshold (such as 95% for measles), "herd immunity" can be used to protect unvaccinated people, which is especially important for people with immune deficiencies.
Vaccine Insights
Collecting data on vaccine development and public concerns.
Data Collection
Gathering insights from various public health sources.
Molecular biology data: Analyze the structure of antigenic proteins (such as mutation sites in the RBD region of the coronavirus spike protein) through sequencing technology, and use AlphaFold to predict protein folding stability to provide a basis for vaccine design.
The system records the basic information of the vaccination recipients (age, gender, underlying diseases), vaccine batches, vaccination sites, etc. China's "Golden Vaccine System" covers the vaccination records of over 1.4 billion people and can provide real-time statistics on the vaccine coverage rate in each region.
Public Feedback
Analyzing discussions and questions about vaccines online.